Jalid Sehouli
Berlin gynaecological oncologist and ESGO President, a leading ovarian cancer surgeon and trialist within the AGO study group.
Overview
Jalid Sehouli is President of the European Society of Gynaecological Oncology (ESGO) and Director of the Department of Gynecology at Charité University Hospital, Berlin. He is a leading investigator in ovarian cancer surgery and systemic therapy and a co-author of the DESKTOP III trial of secondary cytoreductive surgery for relapsed ovarian cancer. He has long been active in the AGO Study Group and in international ovarian cancer trial collaborations.
| Title | Journal | Year |
|---|---|---|
| Randomized Trial of Cytoreductive Surgery for Relapsed Ovarian Cancer | New England Journal of Medicine | 2021 |
Pages like this
not linked directly; found by shared links- PersonAne Gerda Eriksson
Shares European Society of Gynaecological Oncology, Endometrial cancer, Ovarian cancer and the tags leadership, clinician-scientist, gynaecological oncology.
- PersonAntonio González-Martín
Shares Endometrial cancer, Cervical cancer, Ovarian cancer and the tags leadership, clinician-scientist, gynaecological oncology, ovarian cancer.
- PersonThomas Herzog
Shares Endometrial cancer, Cervical cancer, Ovarian cancer and the tags leadership, clinician-scientist, ovarian cancer.
- PersonSara Y. Brucker
Shares Endometrial cancer, Ovarian cancer and the tags leadership, clinician-scientist, gynaecological oncology.
- PersonSébastien Armanet
Shares Endometrial cancer, Cervical cancer, Ovarian cancer and the tag leadership.
- PersonCharlie Gourley
Shares Ovarian cancer and the tags leadership, clinician-scientist, ovarian cancer.
- PersonRobert S. Mannel
Shares Endometrial cancer, Ovarian cancer and the tags leadership, clinician-scientist.
- PersonKaren H. Lu
Shares Endometrial cancer, Ovarian cancer and the tags leadership, clinician-scientist.